Ibio, Common Stock Stock Alpha and Beta Analysis
| IBIO Stock | USD 4.63 0.07 1.54% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as iBio, Common Stock. It also helps investors analyze the systematic and unsystematic risks associated with investing in IBio, Common over a specified time horizon. Remember, high IBio, Common's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to IBio, Common's market risk premium analysis include:
Beta 0.6 | Alpha 1.3 | Risk 7 | Sharpe Ratio 0.19 | Expected Return 1.33 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
IBio, |
IBio, Common Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. IBio, Common market risk premium is the additional return an investor will receive from holding IBio, Common long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IBio, Common. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate IBio, Common's performance over market.| α | 1.30 | β | 0.60 |
IBio, Common expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of IBio, Common's Buy-and-hold return. Our buy-and-hold chart shows how IBio, Common performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.IBio, Common Market Price Analysis
Market price analysis indicators help investors to evaluate how IBio, Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IBio, Common shares will generate the highest return on investment. By understating and applying IBio, Common stock market price indicators, traders can identify IBio, Common position entry and exit signals to maximize returns.
IBio, Common Return and Market Media
The median price of IBio, Common for the period between Sun, Dec 22, 2024 and Sat, Mar 22, 2025 is 3.17 with a coefficient of variation of 33.24. The daily time series for the period is distributed with a sample standard deviation of 1.19, arithmetic mean of 3.58, and mean deviation of 0.96. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | iBio expands cardiometabolic and obesity program Seeking Alpha | 01/02/2025 |
2 | iBio Expands Pipeline with New Antibody Agreement - Yahoo Finance | 01/03/2025 |
3 | iBio and AstralBio Breakthrough Novel Antibody Targets Obesity and Diabetes Through Activin E Inhibition - StockTitan | 01/07/2025 |
4 | iBio, Inc. CFO Felipe Duran Acquires 9,191 Shares of Stock | 01/14/2025 |
5 | Acquisition by Brenner Martin of 700000 shares of Ibio subject to Rule 16b-3 | 01/27/2025 |
6 | iBio GAAP EPS of -0.48 | 02/10/2025 |
7 | Opaleye Management Inc. Acquires Additional Shares in iBio Inc. | 02/14/2025 |
8 | iBio to Begin Trading on the Nasdaq Stock Exchange - GlobeNewswire | 02/20/2025 |
9 | Acquisition by Brenner Martin of 230700 shares of IBio, Common at 3.48 subject to Rule 16b-3 | 02/21/2025 |
10 | Disposition of 37243 shares by Randy Maddux of IBio, Common at 0.6832 subject to Rule 16b-3 | 03/14/2025 |
About IBio, Common Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including IBio, or other stocks. Alpha measures the amount that position in iBio, Common Stock has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | |
| Dividend Yield | 0.0372 | 0.033 |
| Price To Sales Ratio | 39.36 | 37.39 |
IBio, Common Upcoming Company Events
As portrayed in its financial statements, the presentation of IBio, Common's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, IBio, Common's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of IBio, Common's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of IBio, Common. Please utilize our Beneish M Score to check the likelihood of IBio, Common's management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with IBio, Common
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out IBio, Common Backtesting, IBio, Common Valuation, IBio, Common Correlation, IBio, Common Hype Analysis, IBio, Common Volatility, IBio, Common History and analyze IBio, Common Performance. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
IBio, Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.